Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised equivalence study of the EQ-5D-5L Shona versions: evaluation of measurement equivalence between digital and paper formats.

Health and quality of life outcomes·2026
Same author

Qualitative assessment of content validity of the modified EQ-HWB-9 by patients, caregivers, and social care users in the United States.

Health and quality of life outcomes·2026
Same author

National trends in prescription drug expenditures and projections for 2026.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Item-Level Convergent and Structural Validity of the EQ-HWB-9 in US Informal Caregivers Compared With ASCOT-Carer, CarerQoL, and EQ-5D-5L.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Cardiovascular Risks of Aromatase Inhibitors versus Tamoxifen in Postmenopausal Breast Cancer: A Multinational Cohort Study.

Clinical epidemiology·2026
Same author

Valuing Child Health: An EQ-5D-Y-3L Value Set for the United States.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025

Related Experiment Video

Updated: Jun 21, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Comparative effectiveness research: Relevance and applications to pharmacy.

Glen T Schumock1, A Simon Pickard

  • 1Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street (M/C 886), Chicago, IL 60612, USA. schumock@uic.edu

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|July 4, 2009
PubMed
Summary

Comparative effectiveness research (CER) compares treatments in real-world practice. This growing field provides crucial information for pharmacists making drug therapy decisions.

Related Experiment Videos

Last Updated: Jun 21, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

  • Pharmacoeconomics and Health Services Research

Background:

  • Traditional randomized clinical trials offer limited insights into real-world therapeutic decisions.
  • The U.S. healthcare system faces challenges in health outcomes despite high expenditures.
  • Comparative effectiveness research (CER) addresses these limitations by evaluating interventions in practice.

Purpose of the Study:

  • To provide an overview of comparative effectiveness research (CER).
  • To highlight the relevance of CER to pharmacists and healthcare decision-makers.

Main Methods:

  • CER involves comparing true therapeutic alternatives.
  • Studies examine outcomes in actual clinical practice settings.
  • CER encompasses primary and secondary research designs, comparing drugs, devices, procedures, and services.

Main Results:

  • The U.S. government is significantly investing in CER.
  • CER provides a more comprehensive understanding of treatment effectiveness than traditional studies.
  • CER findings are critical for informed pharmacotherapy and healthcare decisions.

Conclusions:

  • Comparative effectiveness research is a vital and expanding field in healthcare.
  • CER knowledge is essential for pharmacists in drug information and therapy management.
  • CER supports evidence-based decision-making for optimizing patient care and healthcare resource allocation.